FAT4 and colorectal carcinoma: Our study revealed that miR-106b-5p targeting FAT4 had an anti-cancerous effect on CRC by regulating the epithelial–mesenchymal transition (EMT) process, which may provide a theoretical reference for the precise treatment of CRC.